Medizinische Klinik und Poliklinik I, Ludwig Maximilian University Hospital Munich, Munich, Germany.
Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig Maximilian University Munich, Planegg-Martinsried, Germany.
JAMA Cardiol. 2022 Mar 1;7(3):286-297. doi: 10.1001/jamacardio.2021.5133.
Myocardial injury is a common feature of patients with SARS-CoV-2 infection. However, the cardiac inflammatory processes associated with SARS-CoV-2 infection are not completely understood.
To investigate the inflammatory cardiac phenotype associated with SARS-CoV-2 infection compared with viral myocarditis, immune-mediated myocarditis, and noninflammatory cardiomyopathy by integrating histologic, transcriptomic, and proteomic profiling.
DESIGN, SETTING, AND PARTICIPANTS: This case series was a cooperative study between the Ludwig Maximilian University Hospital Munich and the Cardiopathology Referral Center at the University of Tübingen in Germany. A cohort of 19 patients with suspected myocarditis was examined; of those, 5 patients were hospitalized with SARS-CoV-2 infection between March and May 2020. Cardiac tissue specimens from those 5 patients were compared with specimens from 5 patients with immune-mediated myocarditis, 4 patients with non-SARS-CoV-2 viral myocarditis, and 5 patients with noninflammatory cardiomyopathy, collected from January to August 2019.
Endomyocardial biopsy.
The inflammatory cardiac phenotypes were measured by immunohistologic analysis, RNA exome capture sequencing, and mass spectrometry-based proteomic analysis of endomyocardial biopsy specimens.
Among 19 participants, the median age was 58 years (range, 37-76 years), and 15 individuals (79%) were male. Data on race and ethnicity were not collected. The abundance of CD163+ macrophages was generally higher in the cardiac tissue of patients with myocarditis, whereas lymphocyte counts were lower in the tissue of patients with SARS-CoV-2 infection vs patients with non-SARS-CoV-2 virus-associated and immune-mediated myocarditis. Among those with SARS-CoV-2 infection, components of the complement cascade, including C1q subunits (transcriptomic analysis: 2.5-fold to 3.6-fold increase; proteomic analysis: 2.0-fold to 3.4-fold increase) and serine/cysteine proteinase inhibitor clade G member 1 (transcriptomic analysis: 1.7-fold increase; proteomic analysis: 2.6-fold increase), belonged to the most commonly upregulated transcripts and differentially abundant proteins. In cardiac macrophages, the abundance of C1q was highest in SARS-CoV-2 infection. Assessment of important signaling cascades identified an upregulation of the serine/threonine mitogen-activated protein kinase pathways.
This case series found that the cardiac immune signature varied in inflammatory conditions with different etiologic characteristics. Future studies are needed to examine the role of these immune pathways in myocardial inflammation.
心肌损伤是 SARS-CoV-2 感染患者的常见特征。然而,与 SARS-CoV-2 感染相关的心脏炎症过程尚不完全清楚。
通过整合组织学、转录组和蛋白质组谱分析,研究与 SARS-CoV-2 感染相关的炎症性心脏表型与病毒性心肌炎、免疫介导性心肌炎和非炎症性心肌病。
设计、地点和参与者:本病例系列是德国慕尼黑路德维希马克西米利安大学医院和图宾根大学心脏病理转诊中心之间的合作研究。对 19 名疑似心肌炎患者进行了检查;其中 5 名患者于 2020 年 3 月至 5 月期间因 SARS-CoV-2 感染住院。比较了这 5 名患者的心脏组织标本与 5 名免疫介导性心肌炎患者、4 名非 SARS-CoV-2 病毒心肌炎患者和 5 名非炎症性心肌病患者的标本,这些患者的标本于 2019 年 1 月至 8 月收集。
心肌活检。
通过免疫组织化学分析、RNA 外显子捕获测序和基于质谱的心肌活检标本蛋白质组分析测量炎症性心脏表型。
在 19 名参与者中,中位年龄为 58 岁(范围 37-76 岁),15 名参与者(79%)为男性。种族和民族的数据未被收集。在心肌炎患者的心脏组织中,CD163+巨噬细胞的丰度通常较高,而 SARS-CoV-2 感染患者的淋巴细胞计数低于非 SARS-CoV-2 病毒相关性和免疫介导性心肌炎患者。在 SARS-CoV-2 感染患者中,补体级联的成分,包括 C1q 亚基(转录组分析:2.5 倍至 3.6 倍增加;蛋白质组分析:2.0 倍至 3.4 倍增加)和丝氨酸/半胱氨酸蛋白酶抑制剂 G 族成员 1(转录组分析:1.7 倍增加;蛋白质组分析:2.6 倍增加),属于最常见的上调转录本和差异丰度蛋白。在心脏巨噬细胞中,C1q 的丰度在 SARS-CoV-2 感染中最高。对重要信号转导途径的评估发现丝氨酸/苏氨酸丝裂原激活蛋白激酶途径的上调。
本病例系列发现,在具有不同病因特征的炎症性疾病中,心脏免疫特征存在差异。需要进一步研究这些免疫途径在心肌炎症中的作用。